- Home
- CPHC vs QNCX Comparison
CPHC vs QNCX Comparison
Compare CPHC & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPHC
- QNCX
- Stock Information
- Founded
- CPHC 1994
- QNCX 2012
- Country
- CPHC United States
- QNCX United States
- Employees
- CPHC N/A
- QNCX N/A
- Industry
- CPHC Services-Misc. Amusement & Recreation
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CPHC Consumer Discretionary
- QNCX Health Care
- Exchange
- CPHC Nasdaq
- QNCX Nasdaq
- Market Cap
- CPHC 92.5M
- QNCX 100.4M
- IPO Year
- CPHC 1994
- QNCX 2019
- Fundamental
- Price
- CPHC $16.94
- QNCX $1.95
- Analyst Decision
- CPHC
- QNCX Strong Buy
- Analyst Count
- CPHC 0
- QNCX 6
- Target Price
- CPHC N/A
- QNCX $8.00
- AVG Volume (30 Days)
- CPHC 2.1K
- QNCX 447.9K
- Earning Date
- CPHC 11-06-2025
- QNCX 11-12-2025
- Dividend Yield
- CPHC 1.66%
- QNCX N/A
- EPS Growth
- CPHC N/A
- QNCX N/A
- EPS
- CPHC 0.03
- QNCX N/A
- Revenue
- CPHC $60,069,270.00
- QNCX N/A
- Revenue This Year
- CPHC N/A
- QNCX N/A
- Revenue Next Year
- CPHC N/A
- QNCX N/A
- P/E Ratio
- CPHC $558.56
- QNCX N/A
- Revenue Growth
- CPHC N/A
- QNCX N/A
- 52 Week Low
- CPHC $15.91
- QNCX $0.71
- 52 Week High
- CPHC $22.93
- QNCX $2.45
- Technical
- Relative Strength Index (RSI)
- CPHC 54.97
- QNCX 62.85
- Support Level
- CPHC $16.40
- QNCX $1.64
- Resistance Level
- CPHC $17.40
- QNCX $2.16
- Average True Range (ATR)
- CPHC 0.46
- QNCX 0.15
- MACD
- CPHC 0.09
- QNCX 0.03
- Stochastic Oscillator
- CPHC 69.54
- QNCX 64.92
About CPHC Canterbury Park Holding Corporation 'New'
Canterbury Park Holding Corp is in the business of pari-mutuel wagering on horse races and unbanked card games at its canterbury park racetrack and card casino facility in Minnesota. The company has four operating segments. The horse racing segment represents pari-mutuel wagering operations on simulcast and lives horse races; the Casino segment represents unbanked card operations; the food and beverage segment includes concessions, catering, and events services provided at the Racetrack; and the development segment represents its real estate development operations. The firm generates a majority of its revenue from the Casino segment.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.